ICSN 2012 Call For Abstracts

Abstract submission is now closed. Abstracts were solicited for the topics below.

Evaluating New Technologies and Their Readiness for Incorporation Into Organized Screening Programs

New technologies are developed at a fast pace; however, organized screening programs often are not able to readily adapt new technologies due to limited resources, limited data on effectiveness, and other issues. How do organized screening programs decide which new technology is ready for incorporation into policy?

Abstracts were solicited on evaluation of new technologies and their readiness for incorporation into organized screening programs for breast, cervical, colorectal, lung, and other cancers. Examples include bringing personalized screening into organized programs, cervical cancer screening among a vaccinated population, and approaches to priority-setting for incorporating new technologies into organized screening programs. Of particular interest will be abstracts that consider screening technologies that are most relevant in low-resource settings. Equal consideration will be given to the abstract that briefly describes the process that a program has in place for adapting a new technology into an organized program (e.g., consensus guidelines, randomized trial, modeling, and cost-effectiveness study).

Abstracts will be accepted for oral or poster presentation.

Benefits, Harms, and Costs of Cancer Screening Programs/Factors Influencing Policy and Decision Making

Many countries have long-running organized screening programs, and during this time of economic constraints the harms, benefits, and costs of screening are now under closer scrutiny than years past. As programs and populations mature, issues of overdiagnosis, overtreatment, and the appropriate age to begin and stop cancer screening are all subjects of great concern.

Abstracts were solicited on what is known today and provide new insights into the harms, benefits, costs of screening programs, and other relevant issues. Examples include evaluation of risk-based screening, modeling, sensitivity analysis in modeling and its impact on starting/stopping rules and, ultimately, direct or indirect evaluation of a program's impact.

Abstracts will be accepted for oral or poster presentation.

Roles of Allied Health Professionals and Lay Health Workers in Cancer Screening

A growing literature documents that efficient, effective, high-quality cancer screening can be achieved through use of allied health professionals (e.g., nurses, physician assistants, radiographers) and other non-physician staff, including lay health workers, in various aspects of the cancer screening process. Incorporating allied health professionals and/or lay health workers in screening delivery may be more cost-effective than models of care that rely primarily on physicians, and also more feasible in settings where there are physician shortages.

Abstracts were solicited on innovative approaches to incorporating allied health professionals and/or lay health workers in various aspects of cancer screening, from recruitment into screening to interpretation of tests and follow up of positive results. Examples include screening programs in which nurses perform colorectal endoscopy, radiographers interpret mammograms, and lay health workers conduct Pap testing.

Abstracts will be accepted for oral or poster presentation.

Incorporating Cancer Prevention Strategies into Organized Screening Programs

Primary prevention combined with secondary prevention (early detection, screening) may more effectively reduce the burden of cancer and decrease incidence, morbidity and mortality compared to separate prevention efforts. Organized screening programs provide a framework in which primary prevention strategies can be added in order to disseminate multiple prevention messages to populations.

Abstracts were solicited on comprehensive primary and secondary cancer prevention and estimates of their relative effectiveness and interaction. Examples include promoting healthy diet or physical exercise and breast or colon cancer screening; smoking cessation and screening for lung or cervical cancer.

Abstracts will be accepted for poster presentation only.

Screening Participation Rates

The Screening Participation Rates Work Group was established in 2008 by ICSN members with an interest in learning more about how organized colorectal cancer screening programs in different countries define and measure screening participation, and to assess the comparability of colorectal cancer screening participation measures and indicators.

Abstracts were solicited for studies and projects to (a) assess screening participation, particularly for colorectal cancer screening programs, and (b) evaluate factors that influence compliance with screening.

Abstracts will be accepted for poster presentation only.

Colorectal Cancer Cost

The ICSN has focused on identifying, documenting and promoting best practices in the delivery of organized screening programs around the world. One factor organizations must consider when deciding whether to create or expand cancer screening services is the resources (both financial and non-financial) that will be required. The focus of the Colorectal Cancer Cost Work Group is to understand the factors associated with cancer screening and how the cost of screening might be reduced and thus promoted to more organizations.

Abstracts were solicited for studies that address the efforts to understand the resources required for increasing cancer screening, detection, and better treatment. This might include international comparisons of the following: methods for identifying individuals eligible for screening, modes of screening, conveying results, and referring people for diagnostic procedures and treatment.

Abstracts will be accepted for poster presentation only.

Ductal Carcinoma In Situ

The DCIS Work Group grew out of ICSN’s interest in assessing the impact of screening on populations, in particular, screening’s adverse impact. DCIS diagnoses are made at a higher rate in populations that are regularly screened and, therefore, its impact on morbidity could be significant. We are interested in documenting the variation in incidence of DCIS and treatment in populations that are regularly screened.

Abstracts were solicited for studies on (a) reasons for variation in DCIS diagnosis and treatment within and across ICSN screening programs and (b) how to differentiate and manage progressive and indolent DCIS.

Abstracts will be accepted for poster presentation only.


The rate-limiting step in biomarker research is the availability of high-quality specimens. Ongoing population-based studies and infrastructures may be a source of high-quality specimens and data for research on the use of biomarkers in screening programs. The Biomarkers Work Group is interested in the collection and validation of biomarkers at the population level and the possible applications of biomarkers in organized screening programs.

Abstracts were solicited on biomarker collection and validation research within the context of population- level screening studies and the possible applications of biomarkers in screening programs. Topics may include descriptions of resources available for biomarker research, study design for biomarker validation research, and future resource needs for the application of biomarkers in screening programs.

Abstracts will be accepted for poster presentation only.

Audit Feedback on Reading Performance of Screening Mammograms

The effectiveness of screening mammography, cervical screening, and colorectal cancer screening depends on the ability to detect abnormalities and interpret these findings accurately; both tasks are challenging and require ongoing education to maintain and improve interpretative skills. Some countries with mammographic screening programs have developed audit and feedback systems to help screen readers assess and improve their reading skills. These audit feedback systems can include formal systems such as those provided to a program by an independent unit, as well as informal systems in which readers audit their own reading performance or audit feedback is be provided verbally to a reader by a medical leader.

Although the focus of this interest group is on mammographic screening, abstracts were solicited for posters on audit feedback systems for any cancer screening program.

Abstracts will be accepted for poster presentation only.

International Test Sets

The International Test Sets interest group was formed in 2010 for the purpose of sharing knowledge about creation and use of test sets for measuring performance of radiologists in mammography screening. Out of this meeting came a project to develop one or more test sets that could compare interpretation ability internationally and also be used for local evaluation and education.

Abstracts were solicited for posters related to use of test sets for evaluation of clinicians in mammography or any clinical setting (e.g., pathologists, colonoscopists), and test set methodology.

Abstracts will be accepted for poster presentation only.

The abstract submission deadline has now passed. No further abstracts are being accepted.